Can these momentum stocks keep on charging?

Royston Wild considers the investment outlook for two London-quoted risers.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

After a shock profit warning in November punished its share price, sausage casings maker Devro (LSE: DVO) has steadily plotted its way higher again in recent months.

A positive trading statement this week helped the business gain further ground and, while the business conceded some gains in end-of-week trading, the business still rose 11% during Monday-Friday.

Although thin on detail, Devro announced that trading during the year to April 26 “was in line with the Board’s expectations, with total sales volumes ahead of the equivalent period last year.” As a result the Glasgow business affirmed its expectations for the full-year

The news comes as huge relief to tetchy investors following the disaster that was 2016, with signs increasing that sales are hotting up in growth markets like China. And Devro is investing heavily to latch onto its fast-growth regions and has opened new plants in the US and China in the past year alone.

With the firm’s newly launched ‘Devro 100’ programme also aiming to cut costs, improve sales processes and to launch a stream of new products from this year, the profits picture at Devro is looking brighter than it has for some time.

Meaty upside

And despite Devro’s share price ascent of recent months, I believe the food giant still provides exceptional value for money.

The City’s army of abacus-bashers expect earnings to rise 2% and 14% in 2017 and 2018 respectively. And such forecasts leave Devro dealing on a forward P/E ratio of 14.8 times,

Meanwhile, Devro’s expected return to growth is anticipated to lead to the resurrection of its progressive dividend policy. A reward of 8.8p per share shelled out for the past several years is expected to rise to 9p in 2017 and 9.1p next year. And this leaves the stock carrying a monster 4.5% prospective yield.

I reckon these very-undemanding valuations, allied with Devro’s improving top-line performance, could keep driving the share price skywards.

Big riser

Tech titan Computacenter (LSE: CCC) also made impressive gains during the past week, the stock adding 12% in value following a positive reaction to latest trading details on Monday.

Computacenter advised that “while much remains to be done to complete the year, we believe that the Group’s performance for 2017 as a whole will exceed current market expectations due to buoyant market conditions for new investments in technology.”

While Germany was the standout performer during January-March, Computacenter also witnessed “steady progress” in Britain and France in the period, it said.

The company saw group sales rise 16% in the period (or 9% at constant currencies) during the first quarter, and while weak conditions in the first half of last year may have flattered the latest release, Computacenter should keep delivering decent revenues growth as digitalisation picks up across all its regions.

So although Computacenter is expected to see earnings stagnate in 2017, growth is expected to accelerate thereafter starting with a 3% advance in 2018. Given the huge structural opportunities opening up to the business, I reckon a forward P/E ratio of 15 times is great value and could lead to additional share price strength.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has no position in any shares mentioned. The Motley Fool UK owns shares of and has recommended Devro. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »